Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Rheumatoid Arthritis

  Free Subscription


Articles published in Eur J Immunol

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    November 2024
  1. DOMINGUEZ-LUIS MJ, Castro-Hernandez J, Santos-Concepcion S, Diaz-Martin A, et al
    Modulation of the K/BxN arthritis mouse model and the effector functions of human fibroblast-like synoviocytes by liver X receptors.
    Eur J Immunol. 2024;54:e2451136.
    PubMed     Abstract available


    June 2024
  2. WANG P, Xu L, Bai M, Zheng X, et al
    MDSCs are important osteoclast precursors primed by B cells in rheumatoid arthritis.
    Eur J Immunol. 2024 Jun 24:e2350823. doi: 10.1002/eji.202350823.
    PubMed     Abstract available


    April 2024
  3. XU Z, Moreno-Giro A, Zhao D, Kramer A, et al
    Fcgr2b and Fcgr3 are the major genetic factors for cartilage antibody-induced arthritis, overriding the effect of Hc encoding complement C5.
    Eur J Immunol. 2024;54:e2350659.
    PubMed     Abstract available


    December 2023
  4. BEKIC M, Tomic S
    Myeloid-derived suppressor cells in the therapy of autoimmune diseases.
    Eur J Immunol. 2023;53:e2250345.
    PubMed     Abstract available


  5. BUCKNER JH
    Translational immunology: Applying fundamental discoveries to human health and autoimmune diseases.
    Eur J Immunol. 2023;53:e2250197.
    PubMed     Abstract available


    May 2023
  6. ALAMINO VA, Onofrio LI, Del Valle Acosta C, Ferrero PV, et al
    Tofacitinib treatment of Rheumatoid Arthritis: increases senescent T cell frequency in patients and limits T cell function in vitro.
    Eur J Immunol. 2023 May 13:e2250353. doi: 10.1002/eji.202250353.
    PubMed     Abstract available


    January 2023
  7. MERINO-VICO A, Frazzei G, van Hamburg JP, Tas SW, et al
    Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches.
    Eur J Immunol. 2023;53:e2149675.
    PubMed     Abstract available


    November 2022
  8. WANG S, Zhou Y, Huang J, Li H, et al
    Advances in experimental models of rheumatoid arthritis.
    Eur J Immunol. 2022 Nov 3. doi: 10.1002/eji.202249962.
    PubMed     Abstract available


  9. RANI L, Kumar A, Karhade J, Pandey G, et al
    IL-3 regulates the differentiation of pathogenic Th17 cells.
    Eur J Immunol. 2022;52:1842-1858.
    PubMed     Abstract available


    September 2022
  10. HEMON MF, Lambert NC, Roudier J, Auger I, et al
    PAD2 immunization induces ACPA in wild-type and HLA-DR4 humanized mice.
    Eur J Immunol. 2022;52:1464-1473.
    PubMed     Abstract available


    September 2021
  11. PALASIEWICZ K, Umar S, Romay B, Zomorrodi RK, et al
    Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
    Eur J Immunol. 2021;51:2330-2340.
    PubMed     Abstract available


    August 2021
  12. JIANG C, Wu X, Li X, Li M, et al
    Loss of microRNA-147 function alleviates synovial inflammation through ZNF148 in rheumatoid and experimental arthritis.
    Eur J Immunol. 2021;51:2062-2073.
    PubMed     Abstract available


    June 2021
  13. HENSVOLD A, Klareskog L
    Towards Prevention of Autoimmune Diseases: The Example of Rheumatoid Arthritis.
    Eur J Immunol. 2021 Jun 10. doi: 10.1002/eji.202048952.
    PubMed     Abstract available


    April 2021
  14. UMAR S, Palasiewicz K, Van Raemdonck K, Volin MV, et al
    CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts.
    Eur J Immunol. 2021;51:903-914.
    PubMed     Abstract available


  15. ESTRADA-CAPETILLO L, Aragoneses-Fenoll L, Dominguez-Soto A, Fuentelsaz-Romero S, et al
    CD28 is expressed by macrophages with anti-inflammatory potential and limits their T-cell activating capacity.
    Eur J Immunol. 2021;51:824-834.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.